| FLORIDA                                                                         | 11-3331350                                            |
|---------------------------------------------------------------------------------|-------------------------------------------------------|
| (State                  or other jurisdiction of incorporation or organization) | (I.R.S.                  Employer Identification No.) |

----

| UniverCell                  Holdings, Inc.      |       |
|-------------------------------------------------|------------|
| Consolidated                  Balance Sheets    |       |
|                                            |       |   |   |   |   |
| **ASSETS**                                      |       |
|                                            |       |   |   |   |   |
|                                            |       | **June                  30,** | ** ** | **December                  31,** | ** ** |
| ** **                                      | ** ** | **2005** | ** ** | **2004** |   |
|                                            |       | (Unaudited) |   |   |   |
| Current                  Assets                 |       |   |   |   |   |
| Cash                                            |       | $ | 12,950 |   | $ | 14,077 |   |
| Accounts                  Receivable            |       |   |   |   |   | 31,048 |   |
|                                            |       |   |   |   |   |   |   |
| Total                  Current Assets           |       |   | 12,950 |   |   | 45,125 |   |
|                                            |       |   |   |   |   |   |   |
| Property                  & Equipment (Net) |       |   | — |   |   | 9,799 |   |
|                                            |       |   |   |   |   |   |   |
| Total                  Other Assets             |       |   | — |   |   | 9,799 |   |
|                                            |       |   |   |   |   |   |   |
| Total                  Assets                   |       | $ | 12,950 |   | $ | 54,924 |   |

----

| **LIABILITIES                  AND STOCKHOLDERS' EQUITY**                                                                             |       |
|---------------------------------------------------------------------------------------------------------------------------------------|------------|
|                                                                                                                                  |       |   |   |   |   |
|                                                                                                                                  |       | **June                  30,** | ** ** | **December                  31,** | ** ** |
| ** **                                                                                                                            | ** ** | **2005** | ** ** | **2004** |   |
|                                                                                                                                  |       | (Unaudited) |   |   |   |
| Current                  Liabilities                                                                                                  |       |   |   |   |   |
| Accounts                  Payable                                                                                                     |       | $ | 18,953 |   | $ | 403,565 |   |
| Accrued                  Expenses                                                                                                     |       |   | 75,808 |   |   | 37,904 |   |
|                                                                                                                                  |       |   |   |   |   |   |   |
| Total                  Current Liabilities                                                                                            |       |   | 94,761 |   |   | 441,469 |   |
|                                                                                                                                  |       |   |   |   |   |   |   |
| Stockholders'                  Equity                                                                                                 |       |   |   |   |   |   |   |
| Common                  Stock, Authorized 200,000,000 Shares, $.0001                                                                  |       |   |   |   |   |   |   |
| Par                  Value, Issued                  and Outstanding 199,250,000 and 119,793,894 Shares,                  Respectively |       |   | 19,925 |   |   | 11,979 |   |
| Additional                  Paid in Capital                                                                                           |       |   | 1,247,664 |   |   | 1,170,326 |   |
| Retained                  Earnings (Deficit)                                                                                          |       |   | (1,349,400 | ) |   | (1,568,850 | ) |
|                                                                                                                                  |       |   |   |   |   |   |   |
| Total                  Stockholders' Equity                                                                                           |       |   | (81,811 | ) |   | (386,545 | ) |
|                                                                                                                                  |       |   |   |   |   |   |   |
| Total                  Liabilities and Stockholders' Equity                                                                           |       | $ | 12,950 |   | $ | 54,924 |   |

----

| UniverCell                  Holdings, Inc.                                 |       |
|----------------------------------------------------------------------------|------------|
| Consolidated                  Statements of Operations                     |       |
| (Unaudited)                                                                |       |
|                                                                       |       |
|                                                                       |       | **For                  the Three Months Ended** | ** ** | **For                  the Six Months Ended** | ** ** |
| ** **                                                                 | ** ** | **June                  30,** | ** ** | **June                  30,** |   |
|                                                                       |       | **2005** | ** ** | **2004** | ** ** | **2005** | ** ** | **2004** |   |
|                                                                       |       |   |   |   |   |   |   |   |   |
| Revenues                                                                   |       | $ | — |   | $ | — |   | $ | — |   | $ | — |   |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Cost                  of Sales                                             |       |   | — |   |   | — |   |   | — |   |   | — |   |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Gross                  Profit (Loss)                                       |       |   | — |   |   | — |   |   | — |   |   | — |   |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Operating                  Expenses                                        |       |   |   |   |   |   |   |   |   |   |   |   |   |
| General                  & Administrative                              |       |   | 73,986 |   |   | 97,980 |   |   | 157,825 |   |   | 221,351 |   |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Total                  Operating Expenses                                  |       |   | 73,986 |   |   | 97,980 |   |   | 157,825 |   |   | 221,351 |   |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Net                  Operating Income (Loss) from continuing Operations    |       |   | (73,986 | ) |   | (97,980 | ) |   | (157,825 | ) |   | (221,351 | ) |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Other                  Income (Expense)                                    |       |   | — |   |   | — |   |   | — |   |   | — |   |
| Interest                  Income                                           |       |   |   |   |   | 294 |   |   | 30 |   |   | 294 |   |
| Interest                  Expense                                          |       |   | — |   |   | (22,908 | ) |   | — |   |   | (91,503 | ) |
| Gain                  (Loss) on disposal (sale) of discontinued operations |       |   | — |   |   | — |   |   | 376,705 |   |   | — |   |
| Total                  Other Income (Expense)                              |       |   | — |   |   | (22,614 | ) |   | 376,735 |   |   | (91,209 | ) |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Net                  Income (Loss)                                         |       | $ | (73,986 | ) | $ | (120,594 | ) | $ | 219,450 |   | $ | (312,560 | ) |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Net                  Income (Loss) Per Share                               |       | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) | $ | (0.00 | ) |
|                                                                       |       |   |   |   |   |   |   |   |   |   |   |   |   |
| Weighted                  Average Shares Outstanding                       |       |   | 159,521,947 |   |   | 113,027,319 |   |   | 199,250,000 |   |   | 104,404,815 |   |

----

| UniverCell                  Holdings, Inc.                                                                    |       |
|---------------------------------------------------------------------------------------------------------------|------------|
| Consolidated                  Statements of Cash Flows                                                        |       |
|                                                                                                          |       |   |   |   |   |   |   |
|                                                                                                          |       | **For                  the six months ended** | ** ** |
| ** **                                                                                                    | ** ** | **June                  30,** | ** ** |
| ** **                                                                                                    | ** ** | **2005** | ** ** | ** ** | ** ** | **2004** |   |
|                                                                                                          |       |   |   |   |   |   |   |
| CASH                  FLOWS FROM OPERATING ACTIVITIES:                                                        |       |   |   |   |   |   |   |
|                                                                                                          |       |   |   |   |   |   |   |
| Net                  Income (Loss)                                                                            |       | $ | 219,450 |   |   |   |   | $ | (312,560 | ) |
| Adjustments                  to Reconcile Net Loss to Net Cash                                                |       |   |   |   |   |   |   |   |   |   |
| Provided                  by Operations:                                                                      |       |   |   |   |   |   |   |   |   |   |
| Depreciation                                                                                                  |       |   | — |   |   |   |   |   | 6,000 |   |
| Amortization                                                                                                  |       |   | — |   |   |   |   |   | 91,490 |   |
| Bad                  Debt Expense                                                                             |       |   | — |   |   |   |   |   | — |   |
| Loss                  (Gain) on sale of subsidiary                                                            |       |   | (376,705 | ) |   |   |   |   | — |   |
| Change                  in Assets and Liabilities                                                             |       |   |   |   |   |   |   |   |   |   |
| (Increase)                  Decrease in Accounts Receivable                                                   |       |   | — |   |   |   |   |   | (47,914 | ) |
| (Increase)                  Decrease in Other Current Assets                                                  |       |   | — |   |   |   |   |   | — |   |
| Increase                  (Decrease) in Deposits and Prepaids                                                 |       |   | — |   |   |   |   |   | 7,688 |   |
| Increase                  (Decrease) in Accounts Payable/ Accrued Expenses                                    |       |   | 142,021 |   |   |   |   |   | 2,944 |   |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| Net                  Cash Provided(Used) by Operating Activities                                              |       |   | (15,234 | ) |   |   |   |   | (252,352 | ) |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| CASH                  FLOWS FROM INVESTING ACTIVITIES:                                                        |       |   |   |   |   |   |   |   |   |   |
| Proceeds                  from sale of subsidiary                                                             |       |   | 20,000 |   |   |   |   |   | — |   |
| Cash                  Balance transferred in sale                                                             |       |   | (5,893 | ) |   |   |   |   | — |   |
| Purchases                  of Property and Equipment                                                          |       |   | — |   |   |   |   |   | (11,819 | ) |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| Net                  Cash Provided (Used) by Investing Activities                                             |       |   | 14,107 |   |   |   |   |   | (11,819 | ) |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| CASH                  FLOWS FROM FINANCING ACTIVITIES:                                                        |       |   |   |   |   |   |   |   |   |   |
| Cash                  balance transferred in Sale                                                             |       |   |   |   |   |   |   |   |   |   |
| Proceeds                  from Exercise of Stock Options                                                      |       |   | — |   |   |   |   |   | — |   |
| Proceeds                  from Convertible Debentures                                                         |       |   | — |   |   |   |   |   |  — |   |
| Principal                  Payments for Convertible Debentures                                                |       |   | — |   |   |   |   |   |  — |   |
| Principal                  Payments for Capital Leases                                                        |       |   | — |   |   |   |   |   | (1,875 | ) |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| Net                  Cash Provided(Used) by Financing Activities                                              |       |   | — |   |   |   |   |   | (1,875 | ) |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| NET                  INCREASE (DECREASE) IN CASH AND EQUIVALENTS                                              |       |   | (1,127 | ) |   |   |   |   | (266,046 | ) |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| CASH                  AND EQUIVALENTS AT BEGINNING OF PERIOD                                                  |       |   | 14,077 |   |   |   |   |   | 447,989 |   |
|                                                                                                          |       |   |   |   |   |   |   |   |   |   |
| CASH                  AND CASH EQUIVALENTS AT END OF PERIOD                                                   |       | $ | 12,950 |   |   |   |   | $ | 181,943 |   |
|                                                                                                               |
| The                  accompanying notes are an integral part of theses financial                  statements. |

----

| UniverCell                  Holdings, Inc.                                                                   |       |
|--------------------------------------------------------------------------------------------------------------|------------|
| Consolidated                  Statements of Cash Flows (Continued)                                           |       |
|                                                                                                         |       |    |   |   |   |
|                                                                                                         |       | ** For                  the six months ended** | ** ** |
| ** **                                                                                                   | ** ** | ** June                  30,** | ** ** |
| ** **                                                                                                   | ** ** | ** 2005** | ** ** | **2004** |   |
| Cash                  Paid For:                                                                              |       |    |   |   |   |
| Interest                                                                                                     |       |   |   |   |   |
| Taxes                                                                                                        |       | $ | — |   | $ | — |   |
|                                                                                                         |       |   |   |   |   |   |   |
| Non-Cash                  Activities:                                                                        |       |   |   |   |   |   |   |
| Shares                  Issued for Services                                                                  |       |   | — |   |    | — |   |
| Shares                  Issued for Conversion of Debentures and Accrued Interest                             |       |   | — |   | $ | 252,933 |   |
|                                                                                                         |       |   |   |   |   |   |   |
| The                  accompanying notes are an integral part of these financial                  statements. |

----

----

| ·   | general                  economic and business conditions; |
|--------------------|------------------------------------------------------------|

| ·   | our                  ability to implement our business                  strategy; |
|--------------------|-----------------------------------------------------------------------------------|

| ·   | our                  access to financing; |
|--------------------|-------------------------------------------|

| ·   | our                  ability to successfully identify new business                  opportunities; |
|--------------------|----------------------------------------------------------------------------------------------------|

| ·   | our                  ability to attract and retain key                  executives; |
|--------------------|-------------------------------------------------------------------------------------|

| ·   | the                  effect of regulatory and legal                  restrictions. |
|--------------------|------------------------------------------------------------------------------------|

** **

----

|   | 31.1a | Certification                  of Principal Executive Officer - - Rule 13a-14(a)                  Certification |
|--------|-------|-----------------------------------------------------------------------------------------------------------------|

|  | 31.1b | Certification                  of Principal Financial Officer - Rule 13a-14(a)                  Certification |
|--|-------|---------------------------------------------------------------------------------------------------------------|

|   | 32.1 | Certification                  of Principal Executive Officer and Principal Financial Officer                  -                  Sarbanes-Oxley Act Section 906 Certification |
|--------|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                                      |                                                                                                            |                                  |
|-------------------------------------------|-----------------------------------------------------------------------------------------------------------------|---------------------------------------|
|                                      | **UNIVERCELL                HOLDINGS, INC.**                                                                    |
|                                 |                                                                                                       |                             |
| Date: August                19, 2005 | By:                                                                                                   | /s/ Sean                Y. Fulda |
|                                      | Sean Y. FuldaChief                    Executive Officer and PresidentChief                    Financial Officer |